{"resourceType":"ValueSet","id":"2.16.840.1.113883.3.526.3.1287","meta":{"versionId":"19","lastUpdated":"2022-03-02T18:02:48.000-05:00"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1287","version":"20170926","name":"Intolerance to Antineoplastic Therapy","status":"active","date":"2022-03-03T18:46:01-05:00","publisher":"PCPI Steward","compose":{"include":[{"valueSet":["http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1382"]}]},"expansion":{"identifier":"urn:uuid:bed50364-6b82-4529-a465-e60c69f18bb8","timestamp":"2022-06-10T08:56:16-04:00","total":2,"offset":0,"parameter":[{"name":"count","valueInteger":1000},{"name":"offset","valueInteger":0}],"contains":[{"system":"http://snomed.info/sct","version":"http://snomed.info/sct/731000124108/version/20220301","code":"292196008","display":"Antineoplastic adverse reaction (disorder)"},{"system":"http://snomed.info/sct","version":"http://snomed.info/sct/731000124108/version/20220301","code":"292234002","display":"Fluorouracil adverse reaction (disorder)"}]}}